Skip to main content

Closed

AXSM: Axsome Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+42.5% / yr

Operating margin-24.8%

ROIC-50.3%

Financially safe

Stretched

Debt / equity4.03×

Interest coverage-33.1×

Current ratio1.39×

Axsome Therapeutics, Inc.

AXSMNASDAQ Global Market·USD·Closed

Axsome Therapeutics, Inc.

AXSMNASDAQ·USD·Closed

$217.99

−7.10%

$217.99

−$16.65 (7.10%)

52W Range

74thpctl

Volume

0.83×avg

Mkt Cap

11.22BUSD

P/E

-58.4TTM

Div Yield

–ann

52W Range

74thpctl

Volume

0.83×avg

Market Cap

11.22BUSD

P/E Ratio

-58.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings